Trial Details
Not RecruitingBasic Information
| Clinical ID | c5605 |
|---|---|
| Identifier | NL-OMON40895 |
| Trial Title | A study to investigate the safety, tolerability and absorption and elimination of CCX507-B, a new drug for the treatment of patients with inflammatory bowel diseases, in healthy male and female subjects. - CCX507-B SAD/MAD Study. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Crohn's disease. Inflammatory bowel diseases;10017969 |
| Interventions | Group 1a:30 mg CCX507-B or placebo once (in fasted state)30 mg CCX507-B or placebo once daily (in fasted state)30 mg CCX507-B or placebo twice daily (in fasted state)Group 1b:30 mg CCX507-B or placebo once (after breakfast)3 |
Participant Information
| Sponsor | ChemoCentryx, Inc. |
|---|---|
| City | NULL |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | ADULT, ELDER, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |